Health ProductsType I recall

Apo-Amitriptyline: Affected lots may exceed the interim acceptable intake limit for NNORT

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Drugs
Product: Apo-Amitriptyline
Issue: Health products - Product safety
What to do: Consult your health care professional if you have any health concerns.
Distribution: Alberta, British Columbia, Manitoba, Newfoundland and Labrador, Nova Scotia, Ontario, Quebec, Saskatchewan
Audience: General public, Healthcare, Industry
Recall class: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

BrandProduct NameMarket AuthorizationDosage FormStrengthLot
ApoApo-AmitriptylineDIN 02403137TabletAmitriptyline Hydrochloride 10 mgRN6384, RR0265, RR0266, RV1644, RV1645, RW8597, RW8598, TA6008, TA6009, TF8585, TF8586, TF8587, TF8588, TF8589, TW2842, TW2843
ApoApo-AmitriptylineDIN 02403145TabletAmitriptyline Hydrochloride 25 mgRM0519, RM8130, RR0780, RR0781, RV1656, RV1657, RW8691, TA6061, TA6062, TF8602, TF8603

Issue

Affected lots exceed or may exceed the interim acceptable intake limit for N-nitroso-nortriptyline (NNORT)

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime